UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 15, 2026
Sale
Calculated transaction value
$1.37M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 14, 2026
Public filing date
Sep 15, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$502.7
Sep 14, 2026
Close before public filing
$502.7
Sep 14, 2026
Return since public filing
-1.08%
Through Sep 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,722 shares @ $504.47
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000141
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$5.91M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 14, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 14, 2026 | $793.4K |
| United Therapeutics Corp UTHR | Sale | Sep 14, 2026 | $1.19M |
| United Therapeutics Corp UTHR Current | Sale | Sep 14, 2026 | $1.37M |
| United Therapeutics Corp UTHR | Sale | Sep 14, 2026 | $1.21M |
| United Therapeutics Corp UTHR | Sale | Sep 14, 2026 | $222.85K |
| United Therapeutics Corp UTHR | Exercise | Sep 14, 2026 | $0 |